Candriam Luxembourg S.C.A. Lowers Stake in HCP, Inc. (HCP)

Candriam Luxembourg S.C.A. lessened its stake in shares of HCP, Inc. (NYSE:HCP) by 91.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 37,518 shares of the real estate investment trust’s stock after selling 426,501 shares during the quarter. Candriam Luxembourg S.C.A.’s holdings in HCP were worth $1,044,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the business. FMR LLC raised its position in shares of HCP by 2.4% in the 1st quarter. FMR LLC now owns 214,161 shares of the real estate investment trust’s stock worth $6,699,000 after buying an additional 5,007 shares during the period. Eqis Capital Management Inc. grew its stake in shares of HCP by 7.7% during the second quarter. Eqis Capital Management Inc. now owns 14,048 shares of the real estate investment trust’s stock valued at $449,000 after acquiring an additional 1,009 shares in the last quarter. LS Investment Advisors LLC grew its stake in shares of HCP by 5.4% during the second quarter. LS Investment Advisors LLC now owns 27,975 shares of the real estate investment trust’s stock valued at $894,000 after acquiring an additional 1,439 shares in the last quarter. Louisiana State Employees Retirement System grew its stake in shares of HCP by 1.0% during the second quarter. Louisiana State Employees Retirement System now owns 29,100 shares of the real estate investment trust’s stock valued at $930,000 after acquiring an additional 300 shares in the last quarter. Finally, Aperio Group LLC grew its stake in shares of HCP by 8.2% during the second quarter. Aperio Group LLC now owns 139,119 shares of the real estate investment trust’s stock valued at $4,446,000 after acquiring an additional 10,560 shares in the last quarter. Hedge funds and other institutional investors own 90.19% of the company’s stock.

A number of equities analysts have issued reports on HCP shares. Bank of America cut shares of HCP from a “buy” rating to a “neutral” rating and cut their target price for the stock from $33.00 to $31.00 in a report on Friday, September 22nd. Morgan Stanley dropped their target price on HCP from $31.00 to $29.00 and set an “equal weight” rating on the stock in a report on Monday, September 25th. UBS cut HCP from a “neutral” rating to a “sell” rating and dropped their target price for the stock from $30.00 to $25.00 in a report on Monday, October 2nd. Stifel Nicolaus restated a “hold” rating and issued a $30.00 price target on shares of HCP in a research report on Wednesday, October 4th. Finally, Zacks Investment Research upgraded shares of HCP from a “sell” rating to a “hold” rating in a research report on Thursday, November 9th. Three equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $30.91.

HCP, Inc. (NYSE:HCP) traded down $0.26 during trading hours on Monday, hitting $26.40. 3,275,936 shares of the stock traded hands, compared to its average volume of 3,690,060. HCP, Inc. has a one year low of $25.08 and a one year high of $33.67. The company has a debt-to-equity ratio of 1.17, a quick ratio of 0.61 and a current ratio of 0.61. The company has a market cap of $12,380.00, a P/E ratio of 12.94, a price-to-earnings-growth ratio of 2.84 and a beta of 0.33.

HCP (NYSE:HCP) last posted its quarterly earnings data on Thursday, November 2nd. The real estate investment trust reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.02. The company had revenue of $454.00 million for the quarter, compared to the consensus estimate of $440.60 million. HCP had a net margin of 27.31% and a return on equity of 8.85%. The business’s revenue was down 14.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.72 EPS. research analysts forecast that HCP, Inc. will post 1.93 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, November 21st. Stockholders of record on Monday, November 6th were given a dividend of $0.37 per share. The ex-dividend date of this dividend was Friday, November 3rd. This represents a $1.48 dividend on an annualized basis and a dividend yield of 5.61%. HCP’s payout ratio is 264.29%.

ILLEGAL ACTIVITY NOTICE: “Candriam Luxembourg S.C.A. Lowers Stake in HCP, Inc. (HCP)” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of international copyright & trademark laws. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/12/04/candriam-luxembourg-s-c-a-sells-426501-shares-of-hcp-inc-hcp.html.

HCP Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply